Pharmaceutical Logistics Market: Cold Chain Imperatives

According to Inkwood Research, the global pharmaceutical logistics market is expected to progress at a CAGR of 7.56% over the forecast period 2024 to 2032. Cold chain logistics is pivotal in pharmaceutical logistics, ensuring the safe and effective transportation of temperature-sensitive products. 

Companies are making substantive progress within the cold chain by incorporating energy-efficient refrigeration, implementing emission-reducing transport routes, and utilizing eco-friendly packaging. The COVID-19 pandemic has influenced the transformation of pharmaceutical logistics globally. This transformation is evident with a focus on strategic initiatives by companies post-COVID.

Further, a concerted effort is being made to reinforce cold chain infrastructure by investing in temperature-controlled storage facilities and enhancing last-mile delivery networks. These efforts signify an advancement in transporting pharmaceutical products with a strong focus on environmental sustainability.

Pharmaceutical Logistics Market - Inkwood Research

Optimal Cold Chain Performance in Pharmaceutical Logistics Market

Cold chain logistics is an indispensable aspect of pharmaceutical logistics, ensuring the secure transportation of temperature-sensitive drugs and vaccines. This specialized system meticulously controls temperatures throughout the supply chain, from production to end-user delivery. 

Market Position: According to Inkwood Research, cold chain logistics is anticipated to be the fastest-growing type, with a CAGR of 8.51% in the global market.

Various companies, such as Ember LifeSciences and USADA, specialize in cold chain logistics. They ensure the safe transport of temperature-sensitive goods like pharmaceuticals and food products. These companies offer end-to-end solutions, from storage to transportation, maintaining product integrity throughout the supply chain.

Accordingly, Ember LifeSciences and the US Anti-Doping Agency (USADA) have collaborated to improve blood-sample shipping efficiency for the 2024 US Olympic Team Trials. Ember’s cold chain technology focuses on self-contained, self-monitoring shipping systems for temperature-sensitive pharmaceuticals, vaccines, and lab specimens. 

The Ember Cube provides an integrated solution to common cold chain shipping challenges, ensuring secure transport and preserved efficacy of medical items. USADA has previously used the Ember Cube at multiple 2023 sporting events. This encompasses events like the Boston and New York Marathons and the Ironman World Championship in Hawaii

Further, the Cube’s cloud-based dashboard allowed real-time monitoring of location and temperatures, ensuring optimal conditions for blood samples during transit. This partnership addresses shipment delays and offers a cost-effective, reusable shipping solution. It includes advanced features like self-refrigeration and integrated temperature monitoring, enhancing overall efficiency and reliability in healthcare logistics.

Sustainability as a Strategic Mandate: Pharmaceutical Logistics Market

Sustainability stands as a foundational element in modern pharmaceutical logistics, exerting a substantial impact on industry practices and strategic operations. With increasing global attention on Environmental, Social, and Governance (ESG) standards, sustainability has evolved into a crucial determinant for pharmaceutical companies.

Accordingly, Maersk’s proactive cold chain solutions are revolutionizing pharmaceutical logistics by reducing GHG emissions and enhancing sustainability in cargo transport. It is committed to the Science Based Targets initiative (SBTI), which aims for net-zero emissions by 2040 in alignment with the Paris Agreement. As global regulations on ESG standards tighten, the pharmaceutical industry is redefining its value chain for sustainability. 

In response to the urgent need for sustainable logistics solutions, Maersk developed the groundbreaking Pharma Cold Chain Management (PCCM) solution. This comprehensive offering ensures seamless real-time monitoring and swift intervention in case of cold container malfunctions. It also adheres strictly to Good Distribution Practice (GDP) standards

Further, Maersk’s ECO Delivery Ocean product reduces GHG emissions and costs by transitioning from air to sea freight. This shift underlines pharmaceutical logistics’ domain commitment to sustainability and empowers the demand to meet ambitious emission reduction targets.

Post COVID-19 Resilience | Pharmaceutical Logistics Market 

Pharmaceutical logistics faced unprecedented challenges during COVID-19, notably with the rapid distribution of vaccines. The scale was immense, with over 13 billion doses administered globally and 70% of the world’s population receiving at least one dose. 

Logistics providers like Nippon Express played an important role during the COVID-19 vaccination campaign. They chartered grounded passenger flights and utilized cold storage containers with masses of dry ice to maintain temperature-controlled conditions. This was crucial for vaccines like mRNA, which necessitate ultra-low temperatures, including some as low as minus 70 degrees Celsius.

In response to evolving industry trends, there’s a noticeable transition towards specialized medicines and stricter regulations such as GDP standards. This paradigm is shaping the future of pharmaceutical logistics, prompting companies like Nippon Express to enhance their capabilities. 

The company has invested in infrastructure, including the establishment of four major GDP-certified warehouses in Japan. It’s also developed a comprehensive network comprising 35 GDP-certified stations across 25 countries. These initiatives emphasize the pharmaceutical logistics commitment to ensuring compliance and maintaining high-quality standards throughout the supply chain.

Moreover, Nippon Express is actively pursuing sustainability initiatives within pharmaceutical logistics. Their focus is on developing reusable materials for cold chain transport, advancing real-time monitoring technologies, and implementing standardized quality controls globally. 

Apart from these advancements made by Nippon Express, several other companies have provided ongoing assistance in pharmaceutical logistics, both during and post-COVID. These contributions have been essential in ensuring the efficient distribution of vaccines, medications, and medical supplies. 

Here are some notable contributions by key companies in the pharmaceutical logistics sector post-COVID:

  1. Cardinal Health: Cardinal Health collaborated with healthcare providers and manufacturers to ensure the uninterrupted supply of essential medical products post-COVID, implementing resilient logistics strategies.
  2. Cencora (AmerisourceBergen): The company employed innovative logistics strategies post-COVID to address supply chain challenges and meet increased demand for healthcare products efficiently.
  3. LogiNext: LogiNext leveraged data analytics and AI-driven optimization tools to streamline supply chain operations and reduce transit times. This enhanced inventory management, enabling better responsiveness to market fluctuations and ensuring continuous supply chain flow.
  4. Flipkart and Amazon: Major players like Flipkart and Amazon expanded their healthcare logistics services. This included temperature-controlled warehousing and specialized delivery networks to support the increased demand for pharmaceutical products through e-commerce platforms.
  5. Gati-KWE: The company expanded its cold chain capabilities, investing in technology to improve real-time tracking and temperature control. This ensured the safe and efficient delivery of pharmaceutical products, especially vaccines and critical medications.

Stay up-to-date with what’s trending in the Global Pharmaceutical Logistics Market

The convergence of sustainable cold chain practices, heightened by the demands of COVID-era pharmaceutical logistics, has become a catalyst for market evolution. Major players like Flipkart and Amazon, alongside innovative companies, have expanded cold chain capabilities and employed advanced technologies, ensuring the efficient delivery of critical medications. 

This sustainable approach meets the urgent demand for pharmaceutical products and fosters resilience in supply chains globally. With progressions in the supply chain laying a foundation for continued growth and adaptability in healthcare logistics, the pharmaceutical logistics market is predicted to observe developing growth during the forecast period.

By Harshita Kumari

    Can’t find what you’re looking for? Talk to an expert NOW!

    FAQ

    Pharmaceutical logistics is crucial for maintaining the integrity and efficacy of medications, especially temperature-sensitive products like vaccines and biologics. It ensures that medicines reach patients and healthcare facilities promptly and in optimal condition.

    Pharmaceutical logistics uses technologies such as cold chain monitoring systems, RFID (Radio-Frequency Identification) tracking, GPS-enabled logistics, data analytics, and blockchain to enhance visibility, traceability, efficiency, and compliance throughout the supply chain.